Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

Akebia Therapeutics, Inc. (AKBA) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/18/2023 3 Snow Ellen (SVP, CFO and Treasurer) has filed a Form 3 on Akebia Therapeutics, Inc.
06/08/2023 4 ZUMWALT LEANNE M (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 30,000 shares @ $0
Granted 45,000 options to buy @ $1.2, valued at $54k
06/08/2023 4 ROGERS MICHAEL W (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 30,000 shares @ $0
Granted 45,000 options to buy @ $1.2, valued at $54k
06/08/2023 4 FRIESON RON (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 30,000 shares @ $0
Granted 45,000 options to buy @ $1.2, valued at $54k
06/08/2023 4 Wolf Myles (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 30,000 shares @ $0
Granted 45,000 options to buy @ $1.2, valued at $54k
06/08/2023 4 ADAMS ADRIAN (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 30,000 shares @ $0
Granted 45,000 options to buy @ $1.2, valued at $54k
06/08/2023 4 Smith Cynthia (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 30,000 shares @ $0
Granted 45,000 options to buy @ $1.2, valued at $54k
06/08/2023 4 GILMAN STEVEN C (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 30,000 shares @ $0
Granted 45,000 options to buy @ $1.2, valued at $54k
05/25/2023 4 Hadas Nicole R. (SVP, Chief Legal Officer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 200,000 shares @ $0
Sold 63,186 shares @ $1.2229, valued at $77.3k
Granted 200,000 options to buy @ $0.41, valued at $82k
05/25/2023 4 Dahan Michel (SVP, COO) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 200,000 shares @ $0
Sold 95,478 shares @ $1.2229, valued at $116.8k
Granted 200,000 options to buy @ $0.41, valued at $82k
05/18/2023 4 Burke Steven Keith (SVP, Chief Medical Officer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Sold 63,567 shares @ $1.068, valued at $67.9k
05/18/2023 4 Spellman David A (SVP, CFO and Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Sold 63,567 shares @ $1.068, valued at $67.9k
05/16/2023 4 Hadas Nicole R. (SVP, Chief Legal Officer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 100,000 shares @ $0
05/16/2023 4 Dahan Michel (SVP, COO) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 200,000 shares @ $0
03/03/2023 4 Butler John P. (CEO and President) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Sold 38,259 shares @ $0.8775, valued at $33.6k
Sold 47,239 shares @ $0.8775, valued at $41.5k
Sold 6,370 shares @ $0.8775, valued at $5.6k
03/03/2023 4 Hadas Nicole R. (SVP, Chief Legal Officer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Sold 5,333 shares @ $0.8775, valued at $4.7k
Sold 6,613 shares @ $0.8775, valued at $5.8k
Sold 1,088 shares @ $0.8775, valued at $954.7
03/03/2023 4 Burke Steven Keith (SVP, Chief Medical Officer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Sold 6,613 shares @ $0.8775, valued at $5.8k
Sold 6,400 shares @ $0.8775, valued at $5.6k
Sold 1,110 shares @ $0.8775, valued at $974
03/03/2023 4 Dahan Michel (SVP, COO) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Sold 8,058 shares @ $0.8775, valued at $7.1k
Sold 10,476 shares @ $0.8775, valued at $9.2k
Sold 1,878 shares @ $0.8775, valued at $1.6k
03/03/2023 4 Spellman David A (SVP, CFO and Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Sold 6,400 shares @ $0.8775, valued at $5.6k
Sold 810 shares @ $0.8775, valued at $710.8
03/01/2023 4 Butler John P. (CEO and President) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Sold 38,632 shares @ $0.8132, valued at $31.4k
03/01/2023 4 Burke Steven Keith (SVP, Chief Medical Officer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Sold 7,539 shares @ $0.8132, valued at $6.1k
03/01/2023 4 Spellman David A (SVP, CFO and Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Sold 7,539 shares @ $0.8132, valued at $6.1k
03/01/2023 4 Hadas Nicole R. (SVP, Chief Legal Officer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Sold 6,677 shares @ $0.8132, valued at $5.4k
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Spellman David A (SVP, CFO and Treasurer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 196,200 shares @ $0
Granted 294,300 options to buy @ $0.63, valued at $185.4k
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/01/2022 4 Burke Steven Keith (SVP, Chief Medical Officer) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Sold 1,147 shares @ $0.3625, valued at $415.8
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Wolf Myles (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 13,700 shares @ $0
Granted 20,100 options to buy @ $0.45, valued at $9k
06/09/2022 4 Smith Cynthia (Director) has filed a Form 4 on Akebia Therapeutics, Inc.
Txns: Granted 13,700 shares @ $0
Granted 20,100 options to buy @ $0.45, valued at $9k
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy